Shield Therapeutics Financial Overview
Shield Therapeutics's market cap is currently £73.26M. The company's EPS TTM is p-0.0074615728999999995; its P/E ratio is -3.71; Shield Therapeutics is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
